China’s Dezhan Health said it launched a hemp cosmetics series and a hemp-based drink on the domestic market on a trial basis, and announced a series of asset acquisitions in the big health industry involving industrial hemp, disinfectant, peptide, vaccines and other industries. Also, Deyi Pharmaceutical, a Dezhan subsidiary, said it is advancing research in the chemical synthesis of cannabinoids for medical applications.
China’s Dezhan launches 2 products
Support HempToday with a donation
We appreciate our paying subscribers and strive to deliver the most complete, well-researched and comprehensive news, analysis and commentary about the hemp industries. If you’d like to further support us, click below to make a donation.